Cargando…
Assay for evaluation of proarrhythmic effects of herbal products: Case study with 12 Evodia preparations
Guidelines for preclinical drug development reduce the occurrence of arrhythmia-related side effects. Besides ample evidence for the presence of arrhythmogenic substances in plants, there is no consensus on a research strategy for the evaluation of proarrhythmic effects of herbal products. Here, we...
Autores principales: | Baltov, Bozhidar, Beyl, Stanislav, Baburin, Igor, Reinhardt, Jakob, Szkokan, Phillip, Garifulina, Aleksandra, Timin, Eugen, Kraushaar, Udo, Potterat, Olivier, Hamburger, Matthias, Kügler, Philipp, Hering, Steffen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196857/ https://www.ncbi.nlm.nih.gov/pubmed/37213814 http://dx.doi.org/10.1016/j.toxrep.2023.04.014 |
Ejemplares similares
-
Different pathways for activation and deactivation in Ca(V)1.2: a minimal gating model
por: Beyl, Stanislav, et al.
Publicado: (2009) -
Upward movement of IS4 and IIIS4 is a rate-limiting stage in Ca(v)1.2 activation
por: Beyl, Stanislav, et al.
Publicado: (2016) -
Key role of segment IS4 in Cav1.2 inactivation: link between activation and inactivation
por: Andranovits, Stanislav, et al.
Publicado: (2017) -
Timothy Mutation Disrupts the Link between Activation and Inactivation in Ca(V)1.2 Protein
por: Depil, Katrin, et al.
Publicado: (2011) -
Timothy mutation affects tightly sealing point of Ca(V)1.2 activation gate
por: Depil, Katrin, et al.
Publicado: (2011)